Entity Details

Primary name CO1A1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionP02452
EntryNameCO1A1_HUMAN
FullNameCollagen alpha-1(I) chain
TaxID9606
Evidenceevidence at protein level
Length1464
SequenceStatuscomplete
DateCreated1986-07-21
DateModified2021-06-02

Ontological Relatives

GenesCOL1A1

GO terms

Show/Hide Table
GOName
GO:0001501 skeletal system development
GO:0001503 ossification
GO:0001568 blood vessel development
GO:0001649 osteoblast differentiation
GO:0001957 intramembranous ossification
GO:0001958 endochondral ossification
GO:0002020 protease binding
GO:0005201 extracellular matrix structural constituent
GO:0005576 extracellular region
GO:0005584 collagen type I trimer
GO:0005615 extracellular space
GO:0005737 cytoplasm
GO:0005788 endoplasmic reticulum lumen
GO:0005794 Golgi apparatus
GO:0007596 blood coagulation
GO:0007601 visual perception
GO:0007605 sensory perception of sound
GO:0009612 response to mechanical stimulus
GO:0010718 positive regulation of epithelial to mesenchymal transition
GO:0010812 negative regulation of cell-substrate adhesion
GO:0015031 protein transport
GO:0030020 extracellular matrix structural constituent conferring tensile strength
GO:0030141 secretory granule
GO:0030168 platelet activation
GO:0030198 extracellular matrix organization
GO:0030199 collagen fibril organization
GO:0030335 positive regulation of cell migration
GO:0031012 extracellular matrix
GO:0031960 response to corticosteroid
GO:0032355 response to estradiol
GO:0032964 collagen biosynthetic process
GO:0034504 protein localization to nucleus
GO:0034505 tooth mineralization
GO:0038063 collagen-activated tyrosine kinase receptor signaling pathway
GO:0042493 response to drug
GO:0042542 response to hydrogen peroxide
GO:0042802 identical protein binding
GO:0043434 response to peptide hormone
GO:0043588 skin development
GO:0043589 skin morphogenesis
GO:0044344 cellular response to fibroblast growth factor stimulus
GO:0044691 tooth eruption
GO:0045893 positive regulation of transcription, DNA-templated
GO:0046872 metal ion binding
GO:0048407 platelet-derived growth factor binding
GO:0048706 embryonic skeletal system development
GO:0050776 regulation of immune response
GO:0050900 leukocyte migration
GO:0051591 response to cAMP
GO:0055093 response to hyperoxia
GO:0060325 face morphogenesis
GO:0060346 bone trabecula formation
GO:0060351 cartilage development involved in endochondral bone morphogenesis
GO:0062023 collagen-containing extracellular matrix
GO:0071230 cellular response to amino acid stimulus
GO:0071260 cellular response to mechanical stimulus
GO:0071300 cellular response to retinoic acid
GO:0071306 cellular response to vitamin E
GO:0071356 cellular response to tumor necrosis factor
GO:0071364 cellular response to epidermal growth factor stimulus
GO:0071560 cellular response to transforming growth factor beta stimulus
GO:0090263 positive regulation of canonical Wnt signaling pathway
GO:1902618 cellular response to fluoride

Subcellular Location

Show/Hide Table
Subcellular Location
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR000885 Fibrillar collagen, C-terminalDomainDomain
IPR001007 VWFC domainDomainDomain
IPR008160 Collagen triple helix repeatRepeatRepeat

Diseases

Show/Hide Table
Disease IDSourceNameDescription
166220 OMIMOsteogenesis imperfecta 4 (OI4)An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI4 is characterized by moderately short stature, mild to moderate scoliosis, grayish or white sclera and dentinogenesis imperfecta. The disease is caused by variants affecting the gene represented in this entry.
130060 OMIMEhlers-Danlos syndrome, arthrochalasia type, 1 (EDSARTH1)A form of Ehlers-Danlos syndrome, a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDSARTH1 is an autosomal dominant form characterized by frequent congenital hip dislocation and extreme joint laxity with recurrent joint subluxations and minimal skin involvement. The disease is caused by variants affecting the gene represented in this entry.
114000 OMIMCaffey disease (CAFYD)An autosomal dominant disorder characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age. The disease is caused by variants affecting the gene represented in this entry.
166210 OMIMOsteogenesis imperfecta 2 (OI2)An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI2 is characterized by bone fragility, with many perinatal fractures, severe bowing of long bones, undermineralization, and death in the perinatal period due to respiratory insufficiency. The disease is caused by variants affecting the gene represented in this entry.
166200 OMIMOsteogenesis imperfecta 1 (OI1)An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI1 is a non-deforming form with normal height or mild short stature, and no dentinogenesis imperfecta. The disease is caused by variants affecting the gene represented in this entry.
259420 OMIMOsteogenesis imperfecta 3 (OI3)An autosomal dominant form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI3 is characterized by progressively deforming bones, very short stature, a triangular face, severe scoliosis, grayish sclera and dentinogenesis imperfecta. The disease is caused by variants affecting the gene represented in this entry.
130000 OMIMEhlers-Danlos syndrome, classic type, 1 (EDSCL1)A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. The main features of classic Ehlers-Danlos syndrome are joint hypermobility and dislocation, and fragile, bruisable skin. EDSCL1 inheritance is autosomal dominant. The disease may be caused by variants affecting the gene represented in this entry.
166710 OMIMOsteoporosis (OSTEOP)A systemic skeletal disorder characterized by decreased bone mass and deterioration of bone microarchitecture without alteration in the composition of bone. The result is fragile bones and an increased risk of fractures, even after minimal trauma. Osteoporosis is a chronic condition of multifactorial etiology and is usually clinically silent until a fracture occurs. Disease susceptibility is associated with variants affecting the gene represented in this entry.

Drugs

Show/Hide Table
DrugNameSourceType
DB00048 Collagenase clostridium histolyticumDrugbankbiotech
DB04866 HalofuginoneDrugbanksmall molecule
DB11338 Clove oilDrugbankbiotech
DB12872 Vonicog AlfaDrugbankbiotech
DB13133 Von Willebrand Factor HumanDrugbankbiotech

Interactions

51 interactions

InteractorPartnerSourcesPublicationsLink
CO1A1_HUMANCOCH_HUMANMINT19013156 details
CO1A1_HUMANAT132_HUMANBioGRID, IntAct22645275 details
CO1A1_HUMANZNF16_HUMANUniProt21874239 details
CO1A1_HUMANLYOX_HUMANmatrixdb21690299 details
CO1A1_HUMANAP2A_HUMANIntAct24835590 details
CO1A1_HUMANAP2C_HUMANIntAct24835590 details
CO1A1_HUMANFINC_HUMANDIP, HPRD, matrixdb, MINT20541508 25290767 26848503 8468356 details
CO1A1_HUMANCO5A1_HUMANmatrixdb20979576 details
CO1A1_HUMANKEAP1_HUMANBioGRID, IntAct32296183 details
CO1A1_HUMANARMS2_HUMANIntAct19696174 details
CO1A1_HUMANHTRA1_HUMANHPRD, IntAct15101818 21622153 details
CO1A1_HUMANSPRC_HUMANBioGRID, HPRD, matrixdb26848503 2745554 7034958 details
CO1A1_HUMANIBP3_HUMANBioGRID, HPRD12735930 details
CO1A1_HUMANTHIO_HUMANBioGRID, HPRD12099690 details
CO1A1_HUMANNID1_HUMANBioGRID, HPRD9733643 details
CO1A1_HUMANNID2_HUMANBioGRID9733643 details
CO1A1_HUMANPRELP_HUMANBioGRID, HPRD11847210 details
CO1A1_HUMANPKD1_HUMANBioGRID11752017 details
CO1A1_HUMANVWF_HUMANBioGRID, HPRD3490481 details
CO1A1_HUMANTSP1_HUMANBioGRID, HPRD3571333 details
CO1A1_HUMANMMP2_HUMANBioGRID, HPRD11368514 details
CO1A1_HUMANCO7A1_HUMANBioGRID, HPRD9169408 details
CO1A1_HUMANMATN2_HUMANBioGRID, HPRD12180907 details
CO1A1_HUMANMAG_HUMANBioGRID2446864 details
CO1A1_HUMANBARD1_HUMANBioGRID22990118 details
CO1A1_HUMANBRCA1_HUMANBioGRID22990118 details
CO1A1_HUMANUBC_HUMANBioGRID23314748 details
CO1A1_HUMANCAN1_HUMANBioGRID, HPRD12358155 details
CO1A1_HUMANPDGFA_HUMANBioGRID8900172 details
CO1A1_HUMANPDGFB_HUMANBioGRID, HPRD10446987 8900172 details
CO1A1_HUMANMCPH1_HUMANBioGRID29150431 details
CO1A1_HUMANCDC42_HUMANBioGRID31478661 details
CO1A1_HUMANDISC1_HUMANIntAct31413325 details
CO1A1_HUMANCO1A2_HUMANBioGRID, matrixdb18375391 24981860 26848503 details
CO1A1_HUMANPDIA1_HUMANHPRD, matrixdb1339453 26848503 details
CO1A1_HUMANITA2_HUMANBioGRID, HPRD11359786 11856343 2156854 details
CO1A1_HUMANITB1_HUMANBioGRID2156854 details
CO1A1_HUMANCO1A1_HUMANBioGRID18375391 details
CO1A1_HUMANBMP1_HUMANHPRD11283002 details
CO1A1_HUMANMMP9_HUMANHPRD9878537 details
CO1A1_HUMANC1QR1_HUMANHPRD1377218 details
CO1A1_HUMANPGS2_HUMANHPRD1468447 9675033 details
CO1A1_HUMANITA5_HUMANHPRD1693626 details
CO1A1_HUMANFGF7_HUMANHPRD11973338 details
CO1A1_HUMANCD36_HUMANHPRD2468670 details
CO1A1_HUMANDDR2_HUMANHPRD9659899 details
CO1A1_HUMANPGS1_HUMANHPRD7852349 details
CO1A1_HUMANBGH3_HUMANHPRD11867580 12034705 details
CO1A1_HUMANPAK1_HUMANHPRD10772928 details
CO1A1_HUMANTMPS6_HUMANHPRD12149247 details
CO1A1_HUMANCD44_HUMANHPRD1730778 details